Structural analysis of emerin, an inner nuclear membrane protein mutated in X-linked Emery–Dreifuss muscular dystrophy  by Wolff, Nicolas et al.
Structural analysis of emerin, an inner nuclear membrane protein
mutated in X-linked Emery^Dreifuss muscular dystrophy
Nicolas Wol¡a;1, Bernard Gilquina, Karine Courchaya, Isabelle Callebautb,
Howard J. Wormanc, Sophie Zinn-Justina;*
aDe¤partement d’Inge¤nierie et d’Etudes des Prote¤ines, CEA Saclay, 91191 Gif-sur-Yvette, France
bLaboratoire de Mine¤ralogie-Cristallographie Paris, CNRS UMR 7590, Universite¤s Paris 6/Paris 7, Case 115, 4 place Jussieu,
75252 Paris Cedex 05, France
cDepartments of Medicine and of Anatomy and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
Received 10 May 2001; accepted 15 June 2001
First published online 4 July 2001
Edited by Hans Eklund
Abstract Like Duchenne and Becker muscular dystrophies,
Emery^Dreifuss muscular dystrophy (EDMD) is characterized
by myopathic and cardiomyopathic abnormalities. EDMD has
the particularity of being linked to mutations in nuclear proteins.
The X-linked form of EDMD is caused by mutations in the
emerin gene, whereas autosomal dominant EDMD is caused by
mutations in the lamin A/C gene. Emerin colocalizes with lamin
A/C in interphase cells, and binds in vitro to lamin A/C. Recent
work suggests that lamin A/C might serve as a receptor for
emerin. We have undertaken a structural analysis of emerin, and
in particular of its N-terminal domain, which is comprised in the
emerin segment critical for binding to lamin A/C. We show that
region 2^54 of emerin adopts the LEM fold. This fold was
originally described in the two N-terminal domains of another
inner nuclear membrane protein called lamina-associated protein
2 (LAP2). The existence of a conserved solvent-exposed surface
on the LEM domains of LAP2 and emerin is discussed, as well as
the nature of a possible common target. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Duchenne, Becker and Emery^Dreifuss muscular dystro-
phies all are distinguishable by myopathic and cardiomyo-
pathic abnormalities (reviewed in [1,2]). The ¢rst two types
arise due to genetic defects in the cytoskeletal/plasma mem-
brane-associated protein dystrophin, which is part of the gly-
coprotein complex linking actin to the extracellular matrix.
Emery^Dreifuss muscular dystrophy is linked to mutations
in nuclear proteins, which suggests that its pathophysiology
may be very di¡erent from the other types of muscular dys-
trophy [3,4]. It is due to genetic defects in an inner nuclear
membrane protein named emerin [5] or in lamin A/C [6].
Human emerin is a serine-rich protein of 254 amino acids
[5]. The sequence of emerin is composed of an N-terminal
globular domain of about 50 residues, followed by a poly-
Ser segment, then a region of 100 residues rich in hydrophobic
amino acids comprising the nuclear localization signal [7,8],
again a poly-Ser segment, and ¢nally a C-terminal transmem-
brane region (Fig. 1). To date, more than 50 di¡erent patho-
genic mutations have been described in emerin (http://
www.path.cam.ac.uk/emd/mutation.html), most resulting in
truncated proteins which are not expressed and others causing
amino acid substitutions. Interestingly, despite the di¡erent
mutations in Emery^Dreifuss muscular dystrophy, producing
varying e¡ects on emerin expression, the clinical phenotype of
all the patients is similar.
The functions of inner nuclear membrane proteins are not
completely known, although they are suggested to have a
structural role in maintaining nuclear architecture [9]. Inter-
actions of inner nuclear membrane proteins with nuclear lam-
ina and chromatin have been reported in interphase cells.
Lamin B receptor binds to B-type lamins and chromatin pro-
teins [10,11], lamina-associated protein (LAP) 1 and 2 iso-
forms interact with speci¢c types of lamina and chromatin
[12^15], and emerin probably targets A-type and B-type lam-
ins [16^19].
The intranuclear organization of the chromosomes is not
altered in cells that lack emerin [20]. Thus, emerin is not
necessary for localizing chromosomes at the nuclear periphery
and the muscular dystrophy phenotype is not due to a grossly
altered nuclear organization of the chromatin. Emerin has a
role in cell cycle-dependent events, since it can occur in four
di¡erently phosphorylated forms, three of which appear to be
associated with the cell cycle [21]. In interphase cells, emerin
colocalizes with A-type lamin, whereas during mitosis, emerin
becomes dispersed throughout the cell, no longer colocalizing
with lamin. It then participates in the reconstitution of mem-
branes around the daughter nuclei at telophase [22]. Phos-
phorylation of emerin may be involved in controlling these
events.
Emerin was shown to be absent from the inner nuclear
membrane in most patients with X-linked muscular dystro-
phy. Interestingly, emerin is also largely distributed in the
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endoplasmic reticulum of cells lacking lamin A [17], suggest-
ing that lamin A serves as a receptor for emerin in the nu-
cleus. An interaction between lamin A and residues 1^188 of
emerin was observed using biomolecular interaction analysis
and monoclonal antibodies [18]. By the yeast two-hybrid sys-
tem, region 384^566 at the C-terminus of lamin A was iden-
ti¢ed as essential for the interaction with emerin [19]. How-
ever, no structural data exist at an atomic resolution on the
emerin/lamin A complex.
We here report a structural analysis of the inner nuclear
membrane protein emerin. The work focuses on the emerin
globular N-terminal domain, which has been described as
containing a LEM motif by Lin et al. [23]. This domain is
comprised in the region critical for emerin/lamin A interaction
[18], and is involved in the interaction of emerin with the
DNA binding protein BAF [15].
2. Materials and methods
2.1. Sample preparation
The LEM domain of emerin was predicted to include residues 1^44
[23]. It was extended in order to obtain a well-structured protein
soluble at a millimolar concentration. The ¢nal sequence chosen for
the structural study corresponds to residues 2^54 of emerin. The pep-
tide numbering used in the following study goes from 1 to 53.
Chemical synthesis of the LEM domain was carried out in solid
phase using the Fmoc strategy on an Applied Biosystems 431A. The
protein was puri¢ed by HPLC on a semi-preparative Vydac C18 col-
umn from Merck, and its purity was checked on the corresponding
analytic column in the same solvent conditions. Its molecular weight
was measured by electrospray mass spectrometry. It was found to be
consistent with the expected sequence.
For the analytic ultracentrifugation experiments, the protein con-
centration was 10^50 WM, and the solvent was a bu¡er of 1 mM
sodium phosphate at pH 6.3. For the nuclear magnetic resonance
(NMR) experiments, protein concentration was 1^1.5 mM. The sol-
vent was a bu¡er of 20 mM sodium phosphate at pH 6.3. 3-(Tri-
methylsilyl)[2,2,3,3-2H4]propionate was added as a chemical shift
reference. Two samples were prepared: the ¢rst sample was diluted
in 90% H2O, 10% D2O and the second sample was diluted in 100%
D2O.
2.2. Analytic ultracentrifugation experiments
Sedimentation equilibrium was performed at 298 K on a Beckman
Optima XLA ultracentrifuge using a AN 60 Ti rotor and cells with a
12 mm optical path length. Sample volumes of 100 Wl were centrifuged
at 30 000 and 40 000 rpm. Radial scans of absorbance at 274 nm were
taken at 3 h intervals, and equilibrium was achieved after 60 h. Data
were analyzed using the XL-A/XL-2 software supplied by Beckman.
2.3. NMR experiments
All experiments were carried out at 298 K on a Bruker 600 MHz or
800 MHz spectrometer. Two-dimensional double quantum ¢ltered
correlated spectroscopy (DQF-COSY) [24], total correlated spectros-
copy (TOCSY) [25] and nuclear Overhauser e¡ect spectroscopy (NO-
ESY) [26] experiments were recorded. A DIPSI2 composite pulse was
used for isotropic mixing during 80 ms in the TOCSY experiments. A
set of NOESY experiments were carried out with mixing times of 60,
100, 140, and 180 ms, and using a preparation period of 2 s. The
water signal was suppressed by a WATERGATE sequence [27]. All
experiments were performed in hypercomplex mode. The spectra were
recorded with 512 t1U1024 t2 points (1024 t1U4096 t2 for DQF-
COSY). Data processing was carried out using XWIN-NMR (Bruker)
and FELIX (Biosym Technologies, San Diego, CA, USA) programs.
One-dimensional spectra were recorded before and after each set of
experiments, to ensure that the protein was not structurally modi¢ed
with time.
2.4. Proton resonance frequency assignment
In order to assign each of the protein proton frequencies, spin
systems were identi¢ed on the TOCSY spectra. Sequential assignment
was essentially carried out on the basis of HNi3HKi1 and
HNi3HNi1 nuclear Overhauser e¡ect (nOe) interactions. All non-
labile protons were assigned except Hj of Phe38. The backbone NH
and side chain NH2 were also assigned.
2.5. Experimental restraints
Proton^proton distance restraints were deduced from the analysis
of the NOESY spectra recorded at di¡erent mixing times. The vol-
umes of the nOe cross-peaks were integrated. For each peak, a build-
up curve was constructed by ¢tting the experimental volumes to the
following function of the mixing time: f(dm) = a dm+b d2m. The coef-
¢cient a was taken as a build-up rate of the corresponding nOe.
Calibration of these dipolar correlation rates was achieved on the
basis of the known range of dKN distances. The errors made on the
distances were evaluated to 25%. When comparison of the distances
deduced from peaks found on both sides of the diagonal and in both
solvents (H2O and D2O) showed an error larger than 25%, an error
equal to twice their root mean square deviation (RMSD) was used
[28].
2.6. Structure calculation
A semi-automated iterative assignment procedure was applied for
the assignment of the nOe and the construction of the three-dimen-
Table 1
Experimental restraints and structural statistics for the emerin N-terminal domaina
Number of experimental distance restraints
Unambiguous 1209
Ambiguous 87
Number of violations higher than 0.5 Aî 0
RMSD from ideal values
Bond (Aî ) 0.0061 þ 0.0002
Angle (‡) 0.980 þ 0.022
Energy (kcal/mol)
Bond 33.2 þ 1.8
Angle 233.6 þ 10.3
vdWb 40.8 þ 4.9
nOec 347.9 þ 14.1
Ramachandran analysis (for residues 1^43)d
Residues in favored regions 63.8%
Residues in additional allowed regions 30.0%
Residues in generously allowed regions 5.9%
Residues in disallowed regions 0.3%
Coordinate precision (for residues 1^43, in Aî ) on backbone atoms 0.56 þ 0.11
aAll values are averaged on the 10 X-PLOR structures.
bThe van der Waals energy is calculated with a repel function and the paramallhdg parameters.
cThe values of the square-well nOe are calculated with force constants of 50 kcal/mol/Aî 2.
dCalculated with Procheck-nmr [34].
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sional structures. This procedure is described in detail in Savarin et al.
[29]. A force ¢eld adapted to NMR structure calculation (¢les to-
pallhdg.pro and parallhdg.pro in X-PLOR 3.1) was used. At the
last step, 200 structures were calculated and the 10 best structures
were selected to be analyzed.
3. Results
3.1. Is the N-terminal domain monomeric in solution?
Analytic ultracentrifugation was used in order to character-
ize the oligomerization state of the emerin N-terminal domain.
At equilibrium, a mass corresponding to a monomer was
measured. Thus, the N-terminal domain of emerin does not
self-associate at pH 6.3 and for a concentration lower than
50 WM.
3.2. Proton^proton distances deduced from NOESY
experiments
On the NOESY spectra, 3017 (2035 in H2O, 982 in D2O)
peaks were analyzed. At the end of the assignment and struc-
ture calculation procedure, 116 peaks remained unassigned.
Eighty-¢ve peaks correspond to unknown chemical shifts,
probably characteristic of minor conformations, and 19 to
distances which are higher than 7 Aî on the three-dimensional
structures. On the basis of the 2913 other peaks, 1219 re-
straints were generated. Ten restraints were not used in the
calculations because they led to systematic violations higher
than 0.5 Aî . The structures were calculated on the basis of the
1209 remaining distance restraints, which comprised 87 am-
biguous restraints at the last iteration. The mean number of
unambiguous distance restraints per residue yielded 22.8.
Fig. 1. General organization of emerin as predicted from the analysis of its hydrophobic cluster analysis (HCA) plot [31]. HCA readily detects
an N-terminal globular domain (box 1), then a poly-Ser region, a segment of 100 residues rich in hydrophobic amino acids (boxes 2 and 3)
comprising the nuclear localization signal ([7,8], box 3), again a poly-Ser region, and ¢nally a transmembrane segment (box 4). The protein se-
quence is shown on a duplicated K-helical net with amino acid positions indicated above. The contours of the hydrophobic residues are auto-
matically drawn to form clusters that mainly correspond to the internal faces of regular secondary structures [32]. Symbols: open square, threo-
nine; square with dot inside, serine; diamond, glycine; star, proline.
Fig. 2. A: Stereoview of the 10 ¢nal backbone structures of the emerin N-terminal domain. B: Ribbon representation (in stereo [33]) of the
averaged structure of the emerin N-terminal domain.
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Fig. 3. A: Multiple alignment of LEM-like and LEM domains. Conserved hydrophobic residues are displayed in green, conserved charged resi-
dues in red, conserved polar and neutral residues in magenta and conserved glycines and prolines in blue. B: Stereoview of the backbone struc-
tures of the LEM-like domain of LAP2 (in yellow), the LEM domain of LAP2 (in red) and the LEM domain of emerin (in green). The three
structures were ¢tted on the backbone atoms of residues 1^21, 23^29, 30^41 in emerin and the corresponding residues in the LEM-like and
LEM domains of LAP2. C: A conserved solvent-exposed surface observed on LEM domain structures. Residues of the emerin N-terminal do-
main conserved in all LEM domains are colored red, magenta and green when they are positively charged, polar/neutral, and hydrophobic, re-
spectively.
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3.3. Structural statistics
Analysis of the 10 ¢nal structures (Table 1) of the emerin
N-terminal domain shows that no distance violations larger
than 0.5 Aî are present. Furthermore, the covalent geometry is
respected, as evidenced by the low RMSD value for bond
lengths and valence angles. The value of the van der Waals
energy is small, indicating that there is no incorrect non-
bonded contacts.
3.4. Backbone structure
A backbone superposition of the 10 lowest-energy struc-
tures of the emerin N-terminal domain is shown in Fig. 2A.
The conformation of the backbone (C, N, CK atoms) is well
de¢ned for residues 1^43: the RMSD with respect to the
mean coordinates is close to 0.6 þ 0.1 Aî . The Ramachandran
plot of the protein segment 1^43 con¢rms the good quality of
the structures as no residues are systematically in the disal-
lowed region. Over the 10 structures, the percentage of resi-
dues in the most favored and additional allowed region is
99.7%.
A three-residue N-terminal 310 helix and two large K-heli-
ces, named helix 1 and helix 2, are observed in emerin (Fig.
2B). Inspection of the Ramachandran map shows that the
three helical segments comprise residues Asn2^Asp5 (N-termi-
nal helix), Asp8^Tyr18 (helix 1) and Gly27^Gln43 (helix 2). A
characteristic iCi + 3 hydrogen bond is observed between res-
idues 2 and 5 in the N-terminal helix. The large helices 1 and 2
are K-helices. They are stabilized by six iCi + 4 hydrogen
bonds present in segment 7^16 of helix 1, and 11 iCi + 4
hydrogen bonds present at more than 70% in segment 29^43
of helix 2.
3.5. Side chains
The hydrophobic core of the emerin N-terminal domain is
formed by a large number of leucine residues (Leu6, 11, 14,
15), assisted by additional valine (Val25), isoleucine (Ile20 and
37) and tyrosine (Tyr18, 33, 40) residues. Two polar side
chains, His22 and Glu34, are also more than 80% buried in
the structure. Glu34 makes a salt bridge with Arg30.
4. Discussion
4.1. Emerin N-terminal domain adopts the LEM fold
The emerin N-terminal domain is signi¢cantly related to
several domains of proteins anchored in the inner nuclear
membrane ([23], see Fig. 3A). It is similar to (i) the two N-
terminal domains of human LAP2 (identities of sequence: 16
and 34%) and the N-terminal domain of human MAN-1
(identity: 41%), (ii) the N-terminal domains of Caenorhabditis
elegans M01D7.6 (identity: 39%) and W01G7.5 (identity:
34%), and (iii) the N-terminal domain of Drosophila mela-
nogaster ote¢n (identity: 25%). All these domains are pre-
dicted to adopt a common fold, called the LEM fold. Re-
cently, we have experimentally proven that the two N-
terminal domains of human LAP2, although highly divergent
in sequence, have similar solution structures, and we have
shown that their three-dimensional structures mainly consist
of two large parallel K-helices [30]. This work establishes that
the N-terminal domain of emerin also adopts the LEM fold.
Superimposition of the so-called LEM-like (residues 1^56)
and LEM domains (103^151) of LAP2 with the LEM domain
of emerin is displayed in Fig. 3B. The positioning of the short
N-terminal helix and the two main K-helices is conserved in
the three domains. The root mean square deviation calculated
on the backbone atoms between the K-helices of emerin and
LAP2 LEM domain is equal to 1.1 Aî ; it is 1.7 Aî on the whole
backbone. When comparing emerin to the LAP2 LEM-like
domain, the same calculations yield 1.9 and 3.0 Aî , respec-
tively. Comparison of the LAP2 LEM-like and LEM domains
yields similar values of 1.7 and 3.1 Aî , respectively. These
higher values are due to a slightly di¡erent orientation of helix
2, evaluated to be 15‡, in the LEM-like domain when com-
pared to the LEM domains of emerin and LAP2.
Comparison of the LEM domain sequences shows that
eight positions are systematically hydrophobic (Fig. 3A).
The N-terminal three-residue helix is stabilized by the inter-
action of the ¢rst two conserved hydrophobic residues with
the hydrophobic core of the domain, and the six remaining
conserved hydrophobic residues are buried due to the inter-
action of helix 1 with helix 2. A continuous segment, formed
by residues Thr/Ser36, Arg37, Leu/Val39, Tyr/Leu40, Lys42,
Lys/Arg43 and Leu/Ile44, is also highly conserved (Fig. 3A).
This positively charged segment corresponds to the solvent-
exposed surface of helix 2 (Fig. 3C). It could thus be the
interaction site of LEM domains with a common partner.
Interestingly, most of the residues within this conserved seg-
ment are not found in the LEM-like domain of LAP2 (resi-
dues 4^49), suggesting that LEM-like and LEM domains have
di¡erent biological targets.
4.2. Functional role of emerin LEM domain
Emerin was shown in vitro to bind to lamin A and BAF. In
the case of lamin A, it is known that the 188 ¢rst amino acids
of emerin, comprising the LEM domain, the poly-Ser and the
100-residue domain are su⁄cient for binding to region 384^
566 of lamin A [18,19]. In the case of BAF, mutations in the
LEM domain disrupt emerin binding [15]. Similarly, the N-
terminal region of LAP2 comprising the LEM-like and LEM
domains interacts with BAF alone and with a BAF/DNA
complex. Mutations in the LAP2 LEM domain either before
the 310 helix, at the C-terminus of helix 1, in the loop between
helices 1 and 2, or in helix 2 disrupt BAF binding. Thus, a
consensus appears for a role of LEM domains in protein^
protein interaction. In particular, the LEM domains of
LAP2 and emerin interact with protein BAF, and as the ho-
mology within LEM domains is high (25^41% identity relative
to the emerin LEM domain), this might be a general property
of LEM domains. Further experiments are needed to charac-
terize the LEM^BAF interaction at an atomic level.
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